Pharmaceuticals

Plasma Therapy Market Forecast: How Big Will It Be by 2030?

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plasma therapy market from 2026–2035 with trusted insights from The Business Research Company

How much is the Plasma Therapy Market valued at in 2026, and what valuation is forecast for 2030?

The plasma therapy market has demonstrated significant expansion in its size during recent years. It is projected to increase from $0.61 billion in 2025 to $0.69 billion in 2026, at a compound annual growth rate (CAGR) of 12.6%. This growth experienced in the past can be attributed to factors such as limited public understanding of plasma therapy benefits, continued reliance on traditional medical interventions, an increasing number of orthopedic and sports medicine procedures, the expansion of hospital and clinic infrastructure, and the early integration of PRP in cosmetic applications.

The plasma therapy market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $1.13 billion, demonstrating a compound annual growth rate (CAGR) of 13.0%. This growth over the forecast period is fueled by several factors, including the advancement of innovative PRP and PRF formulations, a surge in regenerative medicine research, the broadening scope of plasma therapy applications for chronic and cardiac injuries, greater acceptance in dermatology and dental care settings, and the proliferation of clinical trials and research institutions. Key trends anticipated during this period encompass the increasing integration of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the wider application in regenerative medicine and orthopedics, a growing presence in dermatology, hair restoration, and plastic surgery procedures, an escalating need for injectable and membrane-based fibrin products, and the merging of research with clinical trials to achieve superior therapeutic results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Drivers Are Influencing The Growth Of The Plasma Therapy Market?

The escalating incidence of osteoarthritis is projected to propel the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), identified as a safe and effective plasma therapy, serves as a concentrated autologous blood growth factor that is injected directly into the joint to offer symptomatic relief by reducing inflammation and slowing the progression of osteoarthritis. For instance, a report from September 2023 by the Journal of Elsevier, a Netherlands-based publishing company, indicates a projected global rise in osteoarthritis cases by 2050. Specifically, this increase is expected to be 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Although autologous chondrocyte implantation and scaffold implants are among other widely used treatments for osteoarthritis, the overall surge in osteoarthritis prevalence is expected to significantly drive the plasma therapy market.

How Is The Plasma Therapy Market Organized Into Various Segments?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

Which Trends Are Shaping Activity Within The Plasma Therapy Market?

Major companies within the plasma therapy market are introducing innovative products like the ESG-410 to address evolving needs and enhance treatment options. The ESG-410 functions as an Electrosurgical Generator, specifically designed to provide versatility and improved efficiency in treating NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. For example, in June 2023, Olympus Corporation, a medical technology company based in Japan, launched this next-generation electrosurgical generator, the ESG-410. It is utilized for managing bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design elements, such as enhanced capacitors, ensuring superior plasma stability during ignition. It offers rapid ignition and optimized plasma stability, showcasing improvements over the ESG-400, particularly when used with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator provides advanced treatment avenues for NMIBC and BPH by offering a range of resection loops, electrodes, and vaporization tools.

Who Are The Prominent Global Companies Shaping The Plasma Therapy Market Landscape?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Plasma Therapy Market?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plasma Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795